Immunomatics is a healthtech company developing AI software to predict donor-recipient compatibility risk.
Immunomatics has raised $100K in total funding. The most recent round was Seed. The last funding was announced in October 2026.
Immunomatics's investors include National Institutes of Health, Myosotis Investments.
Immunomatics is headquartered in San Marcos, United States.
Immunomatics is a healthtech company developing AI software to predict donor-recipient compatibility risk.
Immunomatics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Immunomatics — Funding & Investors." VCBacked, October 6, 2026, https://www.vcbacked.co/company/immunomatics. Accessed November 1, 2026.
VCBacked. (2026). Immunomatics — Funding & Investors. Retrieved November 1, 2026, from https://www.vcbacked.co/company/immunomatics
{{cite web |title=Immunomatics — Funding & Investors |url=https://www.vcbacked.co/company/immunomatics |website=VCBacked |access-date=November 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated